MX2021005246A - Actividad antidiabetica del extracto de neem y combinaciones sinergicas de urolitinas a y b. - Google Patents
Actividad antidiabetica del extracto de neem y combinaciones sinergicas de urolitinas a y b.Info
- Publication number
- MX2021005246A MX2021005246A MX2021005246A MX2021005246A MX2021005246A MX 2021005246 A MX2021005246 A MX 2021005246A MX 2021005246 A MX2021005246 A MX 2021005246A MX 2021005246 A MX2021005246 A MX 2021005246A MX 2021005246 A MX2021005246 A MX 2021005246A
- Authority
- MX
- Mexico
- Prior art keywords
- urolithins
- neem extract
- synergistic combinations
- diabetic activity
- neem
- Prior art date
Links
- 229940082880 azadirachta indica flower extract Drugs 0.000 title abstract 2
- 230000003178 anti-diabetic effect Effects 0.000 title 1
- 239000011885 synergistic combination Substances 0.000 title 1
- 229930186301 urolithin Natural products 0.000 title 1
- RIUPLDUFZCXCHM-UHFFFAOYSA-N Urolithin A Chemical compound OC1=CC=C2C3=CC=C(O)C=C3OC(=O)C2=C1 RIUPLDUFZCXCHM-UHFFFAOYSA-N 0.000 abstract 3
- WXUQMTRHPNOXBV-UHFFFAOYSA-N Urolithin B Chemical compound C1=CC=C2C3=CC=C(O)C=C3OC(=O)C2=C1 WXUQMTRHPNOXBV-UHFFFAOYSA-N 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201841041788 | 2018-11-05 | ||
| US16/672,743 US20200138892A1 (en) | 2018-11-05 | 2019-11-04 | Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b |
| PCT/US2019/059774 WO2020097014A1 (en) | 2018-11-05 | 2019-11-05 | Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021005246A true MX2021005246A (es) | 2021-09-08 |
Family
ID=70460249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021005246A MX2021005246A (es) | 2018-11-05 | 2019-11-05 | Actividad antidiabetica del extracto de neem y combinaciones sinergicas de urolitinas a y b. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20200138892A1 (https=) |
| EP (1) | EP3876968A4 (https=) |
| JP (1) | JP2022536223A (https=) |
| KR (1) | KR20210096121A (https=) |
| CN (1) | CN113226347A (https=) |
| AU (1) | AU2019377432A1 (https=) |
| BR (1) | BR112021008725A2 (https=) |
| CA (1) | CA3118926A1 (https=) |
| MX (1) | MX2021005246A (https=) |
| WO (1) | WO2020097014A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220098228A1 (en) * | 2020-09-28 | 2022-03-31 | Natreon, Inc. | Methods and compositions for improving the immune system and providing immuno-protection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8206753B2 (en) * | 2001-06-20 | 2012-06-26 | Metaproteomics, Llc | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
| JP2005325025A (ja) * | 2004-05-12 | 2005-11-24 | Green Kanpo Seiyaku Kk | 糖尿病予防・治療組成物 |
| WO2006030426A1 (en) * | 2004-09-13 | 2006-03-23 | Amcod Limited | Herbal compositions for treatment of diabetes |
-
2019
- 2019-11-04 US US16/672,743 patent/US20200138892A1/en not_active Abandoned
- 2019-11-05 AU AU2019377432A patent/AU2019377432A1/en not_active Abandoned
- 2019-11-05 MX MX2021005246A patent/MX2021005246A/es unknown
- 2019-11-05 CA CA3118926A patent/CA3118926A1/en active Pending
- 2019-11-05 BR BR112021008725-7A patent/BR112021008725A2/pt not_active Application Discontinuation
- 2019-11-05 KR KR1020217017005A patent/KR20210096121A/ko not_active Ceased
- 2019-11-05 EP EP19881334.7A patent/EP3876968A4/en not_active Withdrawn
- 2019-11-05 JP JP2021524012A patent/JP2022536223A/ja active Pending
- 2019-11-05 CN CN201980085374.9A patent/CN113226347A/zh active Pending
- 2019-11-05 WO PCT/US2019/059774 patent/WO2020097014A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3876968A4 (en) | 2022-09-14 |
| WO2020097014A1 (en) | 2020-05-14 |
| US20200138892A1 (en) | 2020-05-07 |
| BR112021008725A2 (pt) | 2021-08-03 |
| CA3118926A1 (en) | 2020-05-14 |
| KR20210096121A (ko) | 2021-08-04 |
| EP3876968A1 (en) | 2021-09-15 |
| AU2019377432A1 (en) | 2021-06-10 |
| JP2022536223A (ja) | 2022-08-15 |
| CN113226347A (zh) | 2021-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2019006005A3 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA | |
| PH12018501969A1 (en) | Pharmaceutical composition comprising empagliflozin and uses thereof | |
| MX2023012450A (es) | Esketamina para el tratamiento de la depresion. | |
| SG11201811697SA (en) | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof | |
| EP4397372A3 (en) | Methods of treating lennox-gastaut syndrome using fenfluramine | |
| MX2023005014A (es) | Metodos de tratamiento de enfermedades inflamatorias cronicas. | |
| MX2020011817A (es) | Metodos para tratar el linfoma. | |
| MX2020010302A (es) | Uso de ácido (1s,3s)-3-amino-4-(difluorometilideno)ciclopentano-1- carboxílico y ácido (s)-3-amino-4-(difluorometilenil)ciclopent-1-e no-1-carboxílico en eltratamiento contra trastornos oculares. | |
| MX2018005352A (es) | Metodos y composiciones para el tratamiento de amiloidosis. | |
| ZA202104166B (en) | Sulcardine administration for treatment of acute atrial fibrillation | |
| PH12020552241A1 (en) | Use of polar lipids to treat or prevent gestational diabetes mellitus | |
| PH12019501439B1 (en) | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | |
| MX2021005246A (es) | Actividad antidiabetica del extracto de neem y combinaciones sinergicas de urolitinas a y b. | |
| PH12018500817B1 (en) | Pharmaceutical composition comprising metformin and lobeglitazone | |
| Hamidpour et al. | Sage: The functional novel natural medicine for preventing and curing chronic illnesses | |
| EP4470625A3 (en) | A pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting | |
| ZA202001568B (en) | Methods and compositions for treating chronic lung diseases | |
| MX2018002298A (es) | Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos. | |
| EP2566502A4 (en) | METHODS OF TREATING OR PREVENTING CARDIOVASCULAR DISORDERS AND PROVIDING CARDIOVASCULAR PROTECTION | |
| MY186286A (en) | A pharmaceutical composition for improving or preventing progression of chronic kidney disease | |
| ZA202200273B (en) | Animal food composition | |
| MX2019013207A (es) | Metodos y composiciones para tratar la endometriosis y sintomas asociados a la endometriosis. | |
| WO2019221645A3 (en) | Effect of balanites aegyptiaca on the regression of liver fibrosis and cirrhosis | |
| MX2018004394A (es) | Uso de la silimarina en el tratamiento de la turberculosis. | |
| MX2021002993A (es) | Métodos para el tratamiento de la hipertrofia del músculo masetero. |